Argentina might need the first locally-manufactured medical cannabis product as quickly as early 2021. Reports Mj Biz
An official document shared by native pharmaceutical newspaper Pharmabiz reveals that Manuel Limeres, head of Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT), licensed the corporate Laboratorio Alef Medical Argentina to register its Convupidiol product as a medicine.
The ANMAT authorization has a validity of 5 years.
However, Pharmabiz General Manager Cristina Kroll instructed Marijuana Business Daily “the company still needs to get the approval of the first (production) batch” to ensure that Convipidiol to change into successfully accessible to sufferers.
Read extra at